Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
- Cell and Gene Therapy at a Turning Point January 30, 2026
- Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson January 9, 2026
- What Is the Size of the IVD Market in 2025? September 8, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Due to Clinical Laboratory Services, Doctors Can Treat Patients Like Never Before
Global clinical laboratory services market is $168 billion and growing, finds new market research report by Kalorama Information Clinical laboratories are an essential part of the health industry, and as a result the global market for clinical laboratory services grew to an estimated $168.3 billion in 2021 (including $79 billion generated from markets outside the […]
This Week in Cell and Gene Therapy: 10 New Developments to Know (July 11, 2022)
This Week in Cell and Gene Therapy: 14 New Developments to Know (June 27, 2022)
In Vitro Diagnostics Business Outlook: Blood Typing Has Rebounded
In 2021, the world market for blood grouping and blood typing rebounded from a 3.2% decline in 2020 due to COVID-19 impacts, reaching an estimated $945 million in revenues, according to an upcoming issue of the In Vitro Diagnostics Business Outlook. The overall market is expected to stabilize in 2022 and grow at a 1% […]
This Week in Cell and Gene Therapy: 12 New Developments to Know (June 13, 2022)
The Middle East and Africa Region a $4 Billion Hotbed for IVD Investment
Globally, in vitro diagnostic (IVD) companies are exploring opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. As the COVID-19 dust settles, it is expected that the interest in geographic expansion will once again return to the Middle East and […]
Single Cell Genomics in Next-Generation Sequencing (NGS) Market Reaches $780 Million
VIDEO: 5 Key Facts about Point-of-Care (POC) Diagnostic Tests
Learn about these 5 key facts based on research featured in The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition (published April 2022), a recent report by Kalorama Information Watch the one minute video below for insights and important facts regarding the POC diagnostic testing market. And as always, Kalorama Information offers even more […]
AACC Calls on Congress to Halt Legislation That Would Hinder Patient Access to Essential Medical Tests
WASHINGTON – AACC has sent comments to the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee urging the committee not to include the VALID Act in its omnibus Food and Drug Administration (FDA) user fee legislation. VALID would limit the availability of vital laboratory-developed tests, decreasing patient access to life-saving diagnostic tools. View the comments […]
This Week in Cell and Gene Therapy: 14 New Developments to Know (May 23, 2022)